Ocular Therapeutix (OCUL)
(Delayed Data from NSDQ)
$7.60 USD
+0.44 (6.15%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $7.59 -0.01 (-0.13%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Earnings News For OCUL
-
Ocular Therapeutix: Q1 Earnings Snapshot
-
Ocular Therapeutix? Reports First Quarter 2024 Results
-
Ocular Therapeutix (OCUL) Reports Q4 Loss, Misses Revenue Estimates
-
Ocular Therapeutix: Q4 Earnings Snapshot
-
Ocular Therapeutix? Reports Fourth Quarter and Full Year 2023 Results
-
Ocular Therapeutix (OCUL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Ocular Therapeutix: Q3 Earnings Snapshot
-
Ocular Therapeutix (OCUL) Reports Q2 Loss, Tops Revenue Estimates
-
Ocular Therapeutix: Q2 Earnings Snapshot
-
Ocular Therapeutix (OCUL) Reports Q1 Loss, Lags Revenue Estimates
-
Ocular Therapeutix: Q1 Earnings Snapshot
-
Ocular Therapeutix (OCUL) Reports Q4 Loss, Tops Revenue Estimates
-
Ocular Therapeutix: Q4 Earnings Snapshot
-
Ocular Therapeutix (OCUL) Reports Q3 Loss, Lags Revenue Estimates (Revised)
-
Ocular Therapeutix: Q3 Earnings Snapshot
-
Ocular Therapeutix? Reports Third Quarter 2022 Financial Results and Business Update
-
Ocular Therapeutix (OCUL) Reports Q2 Loss, Lags Revenue Estimates
-
Ocular Therapeutix: Q2 Earnings Snapshot
-
Ocular Therapeutix? Reports Second Quarter 2022 Financial Results and Business Update
-
Ocular Therapeutix (OCUL) Reports Q1 Loss, Lags Revenue Estimates
-
Ocular Therapeutix (OCUL) Reports Q4 Loss, Lags Revenue Estimates
-
Ocular Therapeutix (OCUL) Reports Q3 Loss, Tops Revenue Estimates
-
Earnings Preview: Ocular Therapeutix (OCUL) Q3 Earnings Expected to Decline
-
Ocular Therapeutix (OCUL) Reports Q2 Loss, Tops Revenue Estimates
-
Will Ocular Therapeutix (OCUL) Report Negative Earnings Next Week? What You Should Know